Bo Kang
Hengyang, 421001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-Analysis.
Journal: The Annals of pharmacotherapy
Published: February 23, 2025
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials.
Journal: International journal of clinical pharmacy
Published: February 08, 2025
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting System.
Journal: Cardiovascular drugs and therapy
Published: November 14, 2024
Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis.
Journal: Expert review of clinical pharmacology
Published: August 29, 2024
Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives.
Journal: Cell cycle (Georgetown, Tex.)
Published: June 12, 2024
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.
Journal: Blood reviews
Published: January 23, 2024
Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis.
Journal: Journal of endocrinological investigation
Published: December 20, 2023
Sodium glucose cotransporter 2 inhibitors with cardiac arrhythmias in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized placebo-controlled trials.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: August 08, 2023
Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response.
Journal: Molecular biology reports
Published: August 07, 2023
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
Journal: Expert review of clinical pharmacology
Published: September 06, 2022
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management.
Journal: Cardiovascular diabetology
Published: March 31, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026